prevymis
merck sharp & dohme b.v. - letermovir - okužbe s citomegalovirusom - antivirusi za sistemsko uporabo - prevymis je indicirano za profilakso reaktivacije citomegalovirusom (cmv) in bolezni pri odraslih serološko cmv prejemniki [r +] alogenskih krvotvornih matičnih celic presaditev (hsct). upoštevati je treba uradne smernice za ustrezno uporabo protivirusnih agenti.
lamisil 250 mg tablete
novartis pharma gmbh - terbinafin - tableta - terbinafin 250 mg / 1 tableta - terbinafin
lamisil 10 mg/g krema
glaxosmithkline dungarvan ltd - terbinafin - krema - terbinafin 8,8 mg / 1 g - terbinafin
lamisil 10 mg/g dermalno pršilo, raztopina
glaxosmithkline dungarvan ltd - terbinafin - dermalno pršilo, raztopina - terbinafin 8,8 mg / 1 g - terbinafin
lamisil dermgel 10 mg/g gel
glaxosmithkline dungarvan ltd - terbinafin - gel - terbinafin 10 mg / 1 g - terbinafin
lamisil 125 mg tablete
novartis pharma gmbh - terbinafin - tableta - terbinafin 125 mg / 1 tableta - terbinafin
lamisil 10 mg/g krema
glaxosmithkline dungarvan ltd - terbinafin - krema - terbinafin 8,8 mg / 1 g - terbinafin
lamisil 10 mg/g krema
glaxosmithkline consumer healthcare (uk) trading limited - terbinafin - krema - terbinafin 8,8 mg / 1 g - terbinafin
lamisil 10 mg/g krema
glaxosmithkline consumer healthcare (uk) trading limited - terbinafin - krema - terbinafin 8,8 mg / 1 g - terbinafin